A global view of pharma and healthcare and its impact on UK industry.
LATEST >
Empagliflozin approved in the EU for the treatment of chronic kidney disease
The European Commission (EC) has approved Boehringer Ingelheim and Eli Lilly’s Jardiance® (empagliflozin) for the treatment of adults with chronic kidney disease (CKD).
The approval...